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Abstract 
Malnutrition in the form of underweight, stunting, wasting or micronutrient 
deficiency is prevalent in developing countries and has serious health 
consequences, particularly for children and women. Correction of micronutrient 
deficiencies has been perceived as one of the most cost effective ways to 
improve maternal and child health and development. Cultural and dietary 
practices as well as nutrient content of local foods may differ between regions. It 
is therefore important to describe micronutrient status in representative 
population samples in developing countries.  
 
Iron and zinc, two essential nutrients which we get mainly from animal source 
foods, are low in the diet of most of women and children of low and middle 
income countries because of limited food intake, consumption of a 
predominantly vegetarian diet and frequent infections. Zinc deficiency is thought 
to be widespread in these countries and successful replenishment of this single 
nutrient might reduce morbidity and mortality. Globally, diarrhea and 
pneumonia together cause almost one third of all deaths in children less than 5 
years of age. The beneficial effects of preventive as well as therapeutic zinc 
supplementation in reducing diarrheal duration and severity are already 
established. Zinc is now included in the standard treatment protocol for diarrhea 
management. Clinical trials in low-income countries have also shown that zinc 
supplementation to healthy children may prevent the occurrence of childhood 
pneumonia. It is plausible that zinc also may have a therapeutic effect when 
given during an acute episode of pneumonia. This has been assessed only in a 
few trials and the results are conflicting. It has also been observed that zinc given 
for a relatively short period of time (~ 2 weeks) may protect against common 
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childhood infections for up to 6 months beyond the period of administration. 
However, the results from the studies examining this “downstream” effect of 
zinc on prevention of infections are also inconclusive. 
 
We carried out a cross-sectional study in a representative sample of 500 non-
pregnant women, 13-35 years of age in Bhaktapur, Nepal. Plasma was analysed 
for zinc and different biomarkers of iron status. The intake of various nutrients 
was estimated by dietary recalls. We also conducted a clinical trial where we 
enrolled 2,628 cases of community acquired pneumonia to measure the efficacy 
of zinc on the risk of treatment failure, the duration of the enrollment episode 
and whether or not short-term zinc supplementation reduced the incidence of 
infections for the subsequent 6 months. In addition to standard antibiotics for 
pneumonia, children were given zinc sulfate or placebo tablets (age <1 year: 10 
mg, 1 year: 20 mg of zinc) for 14 days.  
 
From these two large community based studies in Nepalese women and children, 
we documented that zinc deficiency was very common and coexisted with iron 
deficiency and anemia. Although, the intake of iron predicted hemoglobin 
concentration, the intake of zinc was not correlated with plasma zinc 
concentration. Despite the high prevalence of zinc deficiency and the fact that 
we have previously demonstrated a beneficial therapeutic effect of zinc on 
diarrhea in this population, we found that zinc neither reduced the duration of 
World Health Organization defined pneumonia nor the risk of treatment failure. 
Nor did short-term zinc administration reduce the burden of diarrheal or 
respiratory illnesses over 6 months of follow up. Vomiting/regurgitation, which 
is a well-known side effect of zinc, was more common among children who 
received zinc than in those who received placebo. Our findings indicate that oral 
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zinc may not have a role in the treatment of community acquired relatively mild 
pneumonia in children. Zinc deficiency was common in this community; 
however, anemia and iron deficiency was substantially less common than 
available national estimates. Iron deficiency explained only half of the total 
anemia prevalence suggesting that other causes of anemia may be prevalent in 
this community. 
  
13 
List of publications 
The thesis is based on the following papers: 
PAPER I Chandyo RK, Strand TA, Ulvik RJ, Adhikari RK, Ulak M, Dixit H, 
Sommerfelt H. Prevalence of iron deficiency and anemia among healthy 
women of reproductive age in Bhaktapur, Nepal. Eur J of Clin Nutr. 2007 
Feb;61:262-9 
 
PAPER II Chandyo RK, Strand TA, Mathisen M, Ulak M, Adhikari RK, Bolann BJ, 
Sommerfelt H. Zinc deficiency is common among healthy women of 
reproductive age in Bhaktapur, Nepal. J. Nutr. 2009 Mar;139:594-7. 
 
PAPER III Valentiner-Branth P, Shrestha PS, Chandyo RK, Mathisen M, Basnet S, 
Bhandari N, Adhikari RK, Sommerfelt H and Strand TA. A randomized 
controlled trial of the effect of zinc as adjuvant therapy in children 2-35 mo 
of age with severe or non-severe pneumonia in Bhaktapur, Nepal. Am J 
Clin Nutr. Jun 1 2010; 91 (6) 
 
PAPER IV Chandyo RK, Shrestha PS, Valentiner-Branth P, Mathisen M,  Basnet S, 
Ulak M, Adhikari RK, Sommerfelt H and Strand TA. Two Weeks of Zinc 
Administration to Nepalese Children with Pneumonia Does Not Reduce the 
Incidence of Pneumonia or Diarrhea During the Next 6 Months.  J Nutr. 
2010 Sep;140(9):1677-82 
  
14 
Contents 
Collaborations…………………………………………………………………...3 
Acknowledgments……………………………………………………………….4 
Abbreviations…………………………………………………………………....9 
Abstract………………………………………………………………………....10 
List of publications………………...…………………………………………...13 
1. Introduction………………………………………………………………...17 
1.1. Malnutrition and micronutrient deficiency………………………….17 
1.2. Anemia and iron deficiency……………………..…………………..19 
1.3. Zinc nutrition and role for maternal health………………………….20 
1.4. Preventive zinc supplementation in children………………………..21 
1.5. Therapeutic use of zinc for diarrhea………………………………...22 
1.6. Therapeutic use of zinc for pneumonia……………………………..23 
1.7. Short course of zinc supplementation and delayed effect…………..27 
1.8. Zinc for childhood mortality reduction……………………………..28 
1.9. Assessment of zinc status in a population…………………………..29 
1.10. Assessment of iron status in a population…………………………..30 
1.11. Interaction between iron and zinc…………………..……………....31 
2. Objectives…………………………………………………………………..32 
  
15 
3. Materials and Methods 
3.1. Study site and demography…………………………………………34 
3.2. Food habits………………………………………………………….35 
3.3. Study design- Cross sectional study………………………………...36 
3.4. Dietary recalls method in the cross-sectional study……………........38 
3.5. Dietary reference intakes……………………………………………38 
3.6. Study design- Clinical trial 
3.6.1. Enrollment and co-intervention………………………………….39 
3.6.2. Follow up procedure for the six months period………………….42 
3.7. Ethical considerations……………………………………………….42 
3.8. Definitions…………………………………………………………...43 
3.9. Data management and statistical analysis…………………………...44 
4. Summary of results 
Paper I- Prevalence of iron deficiency and anemia among healthy women of 
reproductive age in Bhaktapur, Nepal………………………………………….46 
Paper II- Zinc deficiency is common among healthy women of reproductive age 
in Bhaktapur, Nepal…………………………………………………………….49 
Paper III- A randomized controlled trial of the effect of zinc as adjuvant therapy 
in children 2-35 mo of age with severe or non-severe pneumonia in Bhaktapur, 
Nepal……………………………………………………………………………50 
  
16 
Paper IV- Two Weeks of Zinc Administration to Nepalese Children with 
Pneumonia Does Not Reduce the Incidence of Pneumonia or Diarrhea During 
the Next 6 Months …………………………………………………………......53 
5. Discussion 
5.1. Selection and compliance- Cross sectional study…….……………..55 
5.2. Selection and compliance – Clinical trial…………………………...56 
5.3. Iron deficiency and anemia…………………………………….........56 
5.4. Zinc deficiency………………………………………………………58 
5.5. Intake of phytate……………………………………………………..60 
5.6. Interpretation of nutritive and plasma zinc values…………………..61 
5.7. Zinc administration for the treatment of community acquired 
pneumonia…………………………………………………………..62 
5.8. Zinc supplementation and delayed effects………………………….64 
6. Main conclusions and recommendations………………………………......67 
7. References………………………………………………………………….71 
8. Papers I-IV 
 
  
17 
1. Introduction  
1.1. Malnutrition and micronutrient deficiency 
Malnutrition, which usually is accompanied with deficiencies of individual or 
several micronutrients, is an important underlying cause of illness and death, 
particularly in women and children of developing countries [1, 2]. Here, it 
affects approximately one of every five children and more than half of those who 
die under the age of five years, are malnourished [3, 4]. Malnutrition leads to 
increased susceptibility to infectious diseases and contribute to the unacceptably 
high childhood mortality seen in many low-income countries [5]. Interventions 
with correction of micronutrient deficiencies have been shown to reduce 
maternal [6] as well as infant morbidity and mortality [7-9], though some other 
studies could not replicate these beneficial findings [10-12]. There is a need to 
identify which nutrients children and women are deficient of, and to find 
effective and realistic means of dealing with these nutritional disorders. 
 
The underlying causes of malnutrition and micronutrient deficiencies are 
complex and related to socio-economic status and living circumstances, as 
described in the United Nations Children’s Fund (UNICEF) conceptual 
framework of malnutrition [13]. Maternal undernutrition reflected as low body 
mass index (BMI), and stunting in children less than 5 years of age, are two 
common manifestation of malnutrition. In a recent national survey in Nepal 24% 
of non-pregnant women of 13-49 years of age were found to have low BMI (< 
18.5 kg/m2) and half of children under five years of age were stunted [14]. 
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Maternal nutritional deficiency is associated with poor pregnancy outcomes [15], 
low birth weight (LBW) [16] and high growth faltering in children [17]. Women 
in developing countries may be deficient of several micronutrients before they 
become pregnant [18, 19]. Information on the prevalence of such deficiencies is 
to a large extent based on studies from hospitalized patients or from pregnant 
women. Metabolic changes and physiological hemodilution may influence the 
serum and plasma concentrations of micronutrient markers during disease and 
pregnancy. Therefore, laboratory tests may be difficult to interpret. So, sampling 
of presumably healthy non-pregnant women is important in order to get proper 
estimates of the micronutrient status [20]. 
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1.2. Anemia and iron deficiency  
Iron deficiency (ID) is one of the most common nutritional deficiencies in the 
world, particularly in developing countries where it affects every other women 
of reproductive age [21]. Studies from Nepal indicate that as much as two thirds 
of pregnant women suffer from anemia [22, 23]. Women of reproductive age are 
particularly vulnerable to anemia and ID due to inadequate intake, multiple 
pregnancies, recurrent infections and menstrual blood loss. Iron deficiency 
anemia (IDA), especially during the first 6 months of pregnancy, increases the 
risk of preterm delivery, LBW, and other pregnancy related complications [24, 
25]. IDA during pregnancy has also been associated with poorer cognition and 
behavior in children as well as poor mother child interaction and emotional 
attachment during the post–partum period [26].   
 
Daily iron supplementation (60 mg/day) is recommended for all women of 
reproductive age living in countries where the prevalence of anemia is > 40% 
[27]. Iron supplementation is also universally recommended during pregnancy 
and post partum in areas where malnutrition and anemia are prevalent 
irrespective of the women’s body iron status. Similarly, prophylactic iron 
supplementation is recommended for all children in developing countries where 
the prevalence of anemia is > 40% [28, 29].  However, caution is warranted in 
communities where infections are common, as iron supplementation has been 
associated with increased susceptibility to infections [30, 31] . Although, a study 
in Southern Nepal [32] did not find any beneficial or adverse effects of iron and 
folic acid supplementation on mortality, a study in Zanzibar found that those 
who received iron and folic acid had a 12% (95% CI: 2%, 23%) increased risk of 
severe illness leading to hospitalization or death and a 16% (95% CI: 2%, 32%) 
increased risk of adverse effects due to malaria [33]. After publication of this 
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study, World Health Organization (WHO) issued a statement stressing targeted 
rather than universal iron supplementation in communities where infection rates 
or malaria transmission are high, specifically to iron replete children [34]. These 
findings also emphasize the importance of generating more data on iron status in 
different regions [35]. This was also one of the conclusions of a recent meta- 
analysis of iron supplementation which included 26 randomized clinical trials 
(RCT) in children less than 5 years of age [36].   
 
1.3. Zinc nutrition and its role for maternal health 
Zinc is an essential trace element for humans and crucial for normal function of 
the immune system [37-39], DNA synthesis, cellular division, proliferation and 
growth [40].  Severe zinc deficiency may lead to hypogonadism, dwarfism and 
severe growth faltering, increased susceptibility to infections, poor immune 
responses and chronic diarrhea [41]. Fortunately, now such cases of severe zinc 
deficiency are uncommon. However, sub-clinical zinc deficiency is widespread 
globally and probably contributes to the high burden of disease in low income 
countries [42]. It is estimated that one third of the world’s population are at risk 
of developing zinc deficiency [40]. The low intake of zinc containing food along 
with the consumption of food containing high levels of phytate, which impairs 
the absorption of zinc, may be responsible for the high prevalence of zinc 
deficiency [43]. Moreover, the soil in many developing countries contain only 
small amounts of zinc and the agricultural products therefore often contain little 
zinc [44]. To address this wide spread public health problem, WHO/UNICEF/ 
International Zinc Nutrition Consultative Group (IZiNCG) urged for direct 
measurement of dietary zinc intake and/or serum zinc estimation in  
representative populations from different continents, so that intervention 
programs if required could be carried out without further delay [45].  
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Zinc is needed during pregnancy for optimal growth and development of the 
fetus and for maternal tissue expansion [46]. Poor maternal zinc status is 
associated with negative pregnancy outcomes [47, 48] including spontaneous 
abortion, congenital malformations, LBW and preterm delivery [49-51]. 
Although, some studies indicated that prenatal zinc supplementation improved 
maternal and neonatal zinc status and birth weight, available data are consistent  
only for reducing the risk of prematurity [52, 53].  
 
1.4. Preventive zinc supplementation in children 
Preventive zinc trials during the last 2 decades in children of developing 
countries consistently showed beneficial effects on prevention of diarrhea and 
pneumonia [54-56].  A recent meta-analysis, which included 17 clinical trials, 
concluded that zinc supplementation for at least 3 months reduced the incidence 
of diarrhea by 14% ( 95% CI; 7%, 21%), respiratory infections by 8% (95% CI; 
1%, 15%), severe forms of diarrheal illness or dysentery by 15% (95% CI; 5%, 
25%) and severe forms of respiratory illnesses by 20% (95% CI; 8%, 30%) [55].  
Zinc supplementation was also associated with a reduction of the duration of 
diarrhea and respiratory illness, although the latter was not statistically 
significant. In one study, routine zinc supplementation reduced incidence of 
pneumonia when the diagnosis included cough with crepitations or bronchial 
breathing at chest auscultation, or an episode of acute lower respiratory infection 
(ALRI) associated with at least one of WHO defined signs of severe illness [57] 
(OR; 0.74, 95% CI; 0.56, 0.99) but not when the diagnosis was based on 
elevated respiratory rate or mother’s recall (OR; 0.98, 95% CI; 0.86, 1.13). 
Similar findings of positive effects of zinc supplementation only when using 
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specific clinical criteria were also found in a subsequent meta-analysis and meta-
regression analysis done by Roth et al. that included 10 RCTs [56]. 
 
A reduction in the incidence of diarrheal and pneumonia illnesses by routine zinc 
supplementation in children of developing countries could potentially result in a 
mortality reduction [42] and improvement of weight and height [58]. Indeed, a 
previous meta-analysis have found a positive effect of routine zinc 
administration on growth [59], particularly if the child was stunted [60]. 
However, this was not confirmed by a recent meta-analysis by Ramakrishnan et 
al. that included even more studies [61]. Furthermore, in a recently published 
large study in India, almost 2,500 children were given either zinc or placebo for 
four months [62]. The children who were given zinc did not experience 
enhanced ponderal or linear growth despite having reduced risks of pneumonia 
and diarrhea.   
 
1.5. Therapeutic use of zinc for diarrhea 
Several RCTs in different developing countries have found beneficial effects of 
therapeutic zinc given during diarrhea in young children [63-65]. Because of 
this, WHO and UNICEF now recommend oral zinc administration for 10-14 
days for the treatment of childhood diarrhea [66]. A meta-analysis conducted 
after this recommendation also confirmed the beneficial effect of zinc 
supplementation [67]. After the WHO recommendations, other effectiveness 
trials have been conducted and found that zinc not only reduced the duration and 
severity of diarrheal illness but was also associated with increased use of oral 
rehydration solution in the community [68-70]. Antibiotics and symptomatic 
treatment are overused and constitute a ubiquitous problem in most developing 
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countries, irrespective of economic status of the child’s family [71]. This 
problem may be reduced if zinc becomes more commonly used for the treatment 
of childhood diarrhea [68].  
 
In a subgroup analysis among children with acute diarrhea receiving zinc 
supplementation, it was revealed that children who had a comparatively more 
severe infection defined by high fever or C-reactive protein (CRP) concentration 
benefited more than those who had a milder illness [72]. This finding along with 
the fact that zinc especially reduced the incidence of lower severe respiratory 
infections when these were associated severity or with a high CRP concentration 
[56, 57, 73], rendered us to hypothesize that zinc also could have a therapeutic 
effect when given during acute childhood pneumonia.  
 
1.6. Therapeutic use of zinc for pneumonia 
Respiratory infections are among the main causes of consultation in health 
centers and for hospital admissions [74], and pneumonia remains one of the 
leading causes of death in children under the age of 5 years [5]. There has been a 
dramatic reduction in child morbidity and mortality after introduction of the 
conjugated vaccines for Haemophilus influenza type B and Streptococcus 
pneumoniae [75-77]. These two micro-organisms are probably responsible for 
70% of hospitalization caused by bacterial pneumonia [78]. Except for 
respiratory syncytial virus, vaccine development for the other myriad pathogens 
that cause pneumonia in children seems elusive at least in near future [79]. So, 
alternative strategies focusing on reducing the burden of respiratory infections 
should be prioritized.  
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The available data on the therapeutic effect of zinc in childhood pneumonia 
range from reduction of pneumonia duration [80], moderate reduction in 
duration of fever, an effect in boys only, [73] to no effect [81], and even a 
deleterious effect during the hot season or in those who had high CRP 
concentration (>40 mg/dL) upon enrollment [82, 83]. All of these studies were 
based on hospitalized children with severe pneumonia (Table 1) and the efficacy 
of zinc in non-severe pneumonia – which is much more common, has still not 
been assessed.
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1.7. Short-course of zinc supplementation and delayed effects 
The beneficial effects observed by preventive zinc trials, which require daily or 
weekly supplementation for several months, might be difficult to achieve outside 
research settings. The challenges of supplementation programs that require 
frequent administration for longer duration in resource poor settings are well 
described elsewhere [84]. Zinc supplementation given for a shorter time period 
(2 weeks) during acute illnesses was also found to be effective in preventing 
subsequent illnesses and could be a possible strategy to counteract the negative 
effect of zinc deficiency. A meta- analysis from 1999 included three short-course 
zinc supplementation trials and found that the incidence of diarrhea and 
pneumonia was reduced substantially during the subsequent 2-3 months [54]. 
Similarly, a preventive positive effect on diarrhea and pneumonia leading to 
reduction in mortality was observed when short-courses of zinc were given 
along with oral rehydration solution for the treatment of diarrhea among 
Bangladeshi children [85]. The incidence of persistent diarrhea and dysentery 
was decreased but the incidence of ALRI was increased in another trial of short-
course zinc supplementation among children residing in urban slums of Dhaka, 
Bangladesh [86].  
 
The achievement of reductions of morbidity and mortality through short-courses 
of zinc administration are indeed promising because it is feasible to implement, 
inexpensive and could be started when visiting health facilities for other illnesses 
such as diarrhea [87]. However, the available data are mostly based on selected 
children who were malnourished or just recovering from acute or persistent 
diarrhea which limits the generalization of these studies (Table 2). 
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1.8. Zinc for childhood mortality reduction 
Sazawal et al. demonstrated a 68% (95% CI; 11%-88%) reduction in mortality 
in full term but small for gestational age infants that were given zinc for 12 
months [7]. In this trial, a total of 1,154 infants were followed up and given 5 mg 
of zinc sulfate or placebo daily. The implementation of treatment protocol for 
diarrhea with zinc and scaling up zinc program in developing countries may thus 
have the potential to decrease child morbidity and mortality [42, 88]. Two 
studies conducted in Bangladesh also demonstrated that zinc administration 
substantially reduced mortality. In one study, among 1,665 urban poor children 
aged 2-12 months a weekly high dose (70 mg/day) of zinc given for 12 months 
reduced mortality by 85% (95% CI; 33%- 97%) [9]. In another study, zinc 
administration for an average of 7 days to all diarrheal cases was associated with 
a 51% (95% CI; 6%-75%) mortality reduction [85]. The latter study was a 
cluster RCT among 8,070 children who were observed for two years. Further, a 
combined analysis of two recently published large trials on zinc supplementation 
in Southern Nepal [8] and Zanzibar [12] demonstrated a significant mortality 
reduction of 18% (95% CI; 4%-30%) in children older than one year of age. 
However, another large study in 94,359 North Indian children failed to 
demonstrate a significant effect of long term zinc supplementation [10]. It was 
speculated that the lack of effect in this trial was due to the fact that everybody 
also were given iron and folic acid along with zinc or placebo and comparatively 
lower doses of zinc were used (5 mg for < 6 months and 10 mg for older 
children). The latter dose of zinc was also tested among 2,052 hospital born 
LBW children and follow up were done at 3, 6, 9 and 12 months to assess all 
causes of mortality and diarrheal and respiratory illness [11]. Despite significant 
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increased plasma zinc concentration among the zinc recipients, this study neither 
observed any positive effect on morbidity or on mortality.   
 
1.9. Assessment of zinc status in populations 
Zinc deficiency is usually not associated with any specific clinical signs. Serum 
or plasma zinc concentration is the recommended and most widely used marker 
of zinc status [89]. Several factors such as diurnal variation, serum albumin 
level, fasting status, recent intake of food, disease status, age, and sex [72, 90] 
may influence plasma and serum zinc concentration making them unsuitable as 
markers of zinc status in individuals. 
If plasma zinc is not available, the following parameters have been proposed as 
proxies for the estimation of zinc deficiency by the IZiNCG. 1. Prevalence of 
stunting in children; although several other nutritional, genetic, and 
environmental factors might also contribute to stunting in children, it is 
commonly used as a proxy for the prevalence of zinc deficiency [91]. The WHO 
considers the prevalence of stunting >20% in a community as a public health 
indicator and the same cut-off is also used to define that a population is at risk 
for widespread zinc deficiency. A benefit of using stunting prevalence as a proxy 
for the occurrence of zinc deficiency is that the data are available for all 
countries and periodically updated by the WHO 
(http://www.who.int/nutgrowthdb/en/). 2. National Food Balance Sheets can be 
used to find the proportion of the population with inadequate intake of zinc 
based on the amount of bioavailable zinc in national food supplies. 3. Prevalence 
of anemia – as both iron and zinc are mainly from animal food sources and most 
of the food that impairs the absorption of iron also affects zinc [92]. 
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1.10. Assessment of iron status in a population 
Iron deficiency with or without accompanying anemia in populations can be 
detected by using several haematological and biochemical iron parameters. The 
prevalence depends upon body requirements, available resources and the local 
patterns of nutritional deficiencies. Anemia is defined as hemoglobin (Hb) 
concentration and/or hematocrit below a specific cut-off value. In contrast to 
biochemical tests, Hb and hematocrit can be analyzed by a simple device and at 
a low cost which make these analyses readily available in resource poor field 
settings [29]. Assessing the iron status by Hb alone, however, is not sufficient 
since other causes of anemia for instance deficiencies of vitamins A, B9 (folate),  
B12 and C, may be widespread in the population [93-96]. By analyzing ferritin 
and soluble plasma transferrin-receptor (p-TfR) in serum or plasma in addition 
to Hb, one can differentiate between iron depletion due to exhausted iron stores, 
iron-deficient erythropoiesis and iron deficiency anemia. Although, serum 
ferritin in general is a valid indicator of depleted iron stores, this test may be less 
reliable in countries with a high prevalence of infection in the population. This is 
because serum ferritin is increased by the acute phase response during 
inflammatory diseases and infections [97].  Thus, in developing countries which 
in general have a high burden of infectious diseases in the population, it can be 
difficult to use serum ferritin as the single test to identify iron deficiency. The p-
TfR increase quickly when iron stores are depleted [98] and is not affected by 
infection, age, gender or in pregnancy. However, it may increase due to high cell 
turnover such as in hemolytic anemia [99]. The ratio of p-TfR to ferritin has also 
been found to be useful in detecting early iron deficiency [100]. Some other 
markers of iron metabolism like erythrocyte or zinc protoporphyrin, serum iron, 
transferrin saturation, total iron binding capacity and red blood cells indices like 
mean corpuscular volume, proportion of hypochromic red cells, reticulocyte Hb 
content and mean corpuscular hemoglobin are also used to detect iron deficiency 
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in the population [101]. One established approach to determine whether anemia 
is caused by iron deficiency is to give oral iron for 1-2 months. A change in Hb 
of at least 10 g/L indicates iron deficiency [29]. This procedure, however, is 
logistically not easy to perform, especially in poor populations where often 
multiple causes of anemia exist.  
 
1.11. Interaction between iron and zinc 
Iron and zinc share the same competitive pathway for absorption [92]. Although, 
deficiencies of these nutrients are likely to coexist in the same population [102], 
absorption of either nutrient may be reduced when they are given together as 
supplements because of competition in the absorption pathways [31, 103, 104]. 
Intake of high non-heme food impairs the absorption of zinc [105] and a high 
ratio of zinc to iron, especially in aqueous solution, such as derived from 
combined iron and zinc supplements, is also found to affect the absorption of 
iron from the small intestines [106].  
  
32 
2. Objectives of the studies forming the basis for 
this thesis 
1. to assess zinc and iron status in women of reproductive age in Bhaktapur, 
Nepal, 
2. to measure the efficacy of zinc administration during childhood 
community acquired pneumonia on episode duration, and risk of 
treatment failure and,  
3. to measure the efficacy of zinc administration during childhood 
community acquired pneumonia on the incidence of common infections 
for the subsequent six months. 
Specific objectives: 
2.1 Cross-sectional study- in a representative sample of women of reproductive 
age in Bhaktapur, Nepal; 
Objective 2.1.1: to assess the intake and status of iron using dietary recall 
and blood test (paper I). 
Objective 2.1.2: to assess the intake and status of zinc using dietary recall 
methods and determination of plasma zinc concentration (paper II).  
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2.2 Clinical trial 
Objective 2.2.1: to measure the efficacy of zinc administration as 
adjuvant to antibiotics for the treatment of community acquired 
pneumonia among 2-35 month old children, on the risk for treatment 
failure and on episode duration (paper III). 
 
Objective 2.2.2:  to identify whether or not zinc given for 14 days starting 
during an episode of pneumonia reduces the risk of subsequent 
respiratory and diarrheal illnesses over the next 6 months in children in 
Bhaktapur, Nepal (paper IV). 
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3. Materials and methods 
3.1. Study site and demography 
The University of Bergen, Norway in collaboration with the Institute of 
Medicine, Tribhuvan University, Kathmandu established a maternal and child 
health research center at Siddhi Memorial Hospital, Bhaktapur, Nepal. Since 
1997 several studies on micronutrients and childhood infections have been 
conducted here [72, 107-109]. The first of these studies was a trial on the 
efficacy and effectiveness of zinc for adjuvant treatment of acute diarrhea in 
children [63]. The results from this study contributed importantly when WHO 
decided to recommend zinc for the treatment of acute diarrhea in children in 
developing countries [66].  
 
Kathmandu valley includes the districts of Kathmandu, Lalitpur and Bhaktapur. 
Bhaktapur district has a heterogeneous population; most of the people are 
farmers, semi-skilled or unskilled laborers and daily wage earners. Bhaktapur 
municipality, centre of the study site, has a population slightly above 70,000 
according to the 2001 census, and most people have agriculture as their main 
occupation [110]. The study site is located approximately 1,400m above sea 
level and is densely populated (1,895 people/sq km) [111]. For the cross-
sectional study (Paper I and II), we enrolled women residing in the municipality 
only; in the clinical trial, we also enrolled children from the outskirts of 
Bhaktapur municipality who came to seek treatment for pneumonia at our 
hospital.  
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In and around the Bhaktapur municipality, there are about 50 carpet factories 
where migrant families live close to and work in for longer or shorter periods. 
They usually belong to different ethnic groups than the local Newar population 
and come from various regions of Nepal. The “carpet workers” are becoming a 
more and more important part of the Bhaktapur population; we therefore ensured 
that they were adequately represented in the micronutrient survey.  
 
Most of the families in the study area have access to piped drinking water and 
toilet with central drainage. The vaccine coverage is quite high (>90% for all 
routine vaccines on national expanded program on immunization schedule) 
[112] but the proportion who exclusively breastfeed up to 6 months of age is 
quite low. Based on a survey in the study area, 79% of infants below 6 months 
of age had already been given semi-solid foods. 
 
3.2. Food habits 
The traditional residents of Bhaktapur typically consume foods grown in their 
own land, while the migrant population relies mainly on foods purchased in the 
market. Rice and lentils are usually boiled or cooked in pressure or rice cookers, 
whereas curried vegetables are fried in cooking oil. The eating pattern varies 
with the season, workload in the field and availability of foods. Eating outside 
the home, such as in restaurants is not common, particularly among women. 
However, celebrations of different festivals, particularly among the local 
residents are common throughout the year. It is estimated that there are about 50-
60 festival celebrations per year, during which food with some more variations 
and larger amount than the usual daily diet is consumed. Generally, main meals 
of rice with lentils and/or vegetable curry and pickles are consumed twice a day. 
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Different local green leafy vegetables are widely consumed mainly in the winter 
and spring season, depending upon the availability. These green leafy vegetables 
are commonly used dried as an alternative to fresh vegetables during the season 
when the latter are scarce. It is common to consume rice flakes or home-made 
breads from unrefined wheat flour as a mid day snack. 
 
3.3. Study design - Cross-sectional part (objectives 2.1.1 and 2.1.2) 
We used a cluster stratified random sampling procedure for the studies presented 
in paper I and II. We defined two strata, one stratum of local resident women 
and the other of those residing in the carpet factories within the Bhaktapur 
municipality. There are 17 administrative units called Wadas and about 128 
neighbourhoods called Toles in the municipality. We used Toles and the carpet 
factories as the primary sampling units (PSU). A total of 23 Toles and 5 carpet 
factories were randomly selected as PSUs.  
 
Prior to enrollment, we obtained a list of all 2,736 women between 13-35 years 
living in these selected clusters. The enrollment took place from September 2000 
to November 2001. Seven hundred and ninety-two randomly selected women 
were thus selected and approached. We tried to ensure that all women in the 
sampling frame had the same probability of being included in the study. Two 
hundred and ninety-two women whom we approached could not be enrolled, 
mainly because they had moved or did not have time to come to the study clinic 
for enrollment. Most of the women that had moved away were from the carpet 
factory stratum (133 women). Table 3 summarizes the characteristics of those 
that were included in the studies that comprise this thesis. 
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Table 3. Outline of studies included in thesis 
 Cross-sectional Study  Randomized clinical trial 
Objectives To estimate prevalence of 
iron and zinc deficiency and  
identify factors associated 
with it 
To estimate the efficacy of zinc 
as adjuvant therapy during 
community acquired pneumonia 
and morbidity during subsequent 
6 months of follow up 
Sample size 500 2,628 
Disease status Healthy With community acquired 
pneumonia 
Age group 13-35 years 2-35 months 
Study area Bhaktapur municipality Bhaktapur municipality and 
outskirt communities 
Selection/ 
randomization 
procedure 
Random sample, cluster, 
stratified 
Double blind, stratified block 
randomized 
Inclusion criteria Healthy non-pregnant women Children with community 
acquired pneumonia and not 
planning to move from study 
area for at least for 6 months 
Exclusion criteria Women taking vitamins, 
minerals, known case of 
chronic disease or suffering 
from acute illness 
Very severe diseases requiring 
prompt referral to hospital, 
dysentery, cough more than 14 
days, congenital heart disease, 
tuberculosis, severe malnutrition 
or use of antibiotic within last 48 
hours 
Intervention Not applicable 
 
 
 
 
 
Zinc or placebo tablets dispersed 
in water or breast milk for 14 
days along with standard 
antibiotics. 10 mg elemental zinc 
to infants and 20 mg to children 
over 1 year of age 
Follow up Not applicable 
 
Daily for the first 2 weeks then 
passive follow up for 6 months 
Main outcome Proportion with iron and zinc 
deficiency and factors 
associated with zinc and iron 
 
 
Duration of episode illness, 
proportion with treatment failure 
and illness during 6 months of 
follow up 
  
Publications  In Paper I and II In Paper III and IV 
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3.4. Dietary recalls method in the cross-sectional study 
In a sub-sample of 394 women, we administered two 24-hour dietary recalls 
approximately one week apart. The women were asked to recall the foods they 
consumed the previous day from waking up until going to bed. The first recall 
was carried out in the clinic, whereas for the second recall, the field workers 
visited each participating woman in her home. Models of commonly used local 
foods were shown during the interviews to estimate the portion sizes. Both 
recalls were completed by the subgroup of 379 women. We used the mean intake 
of the two recalls in the analysis. 
 
At enrollment, we also administered a semi quantitative food frequency 
questionnaire (FFQ), using a list of 53 locally consumed food items developed 
during a previous survey. The frequency of consumption was categorized into 
never, 1-5 times in the past 6 months, 1-3 times every month, once a week, 2-4 
times a week and once or more per day.  
 
3.5. Dietary Reference Intakes  
Recommended dietary allowance (RDA) and estimated average requirement 
(EAR) are two dietary reference indicators, which are commonly used to 
compare adequacy of nutrient intake. We used the Institute of Medicine, 
National Academy of Science (NAS), U.S., cut-offs for RDA and EAR for zinc 
and iron intake [113]. EAR is the average daily nutrient intake, which is 
estimated to meet the requirement of 50% of healthy individuals of a specific life 
stage and gender. The EAR cut-off values are used to estimate the prevalence of 
inadequate intake in groups or individuals. RDA is set two standard deviations 
above the EAR, and is the intake that is sufficient to meet the nutrient 
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requirement of nearly all (97.5 %) of healthy individuals. Thus, individuals 
having an intake at or above this level have a low probability of being deficient.  
 
3.6. Study design - Clinical trial  
3.6.1. Enrollment and co-intervention 
Eligible children were recruited from Siddhi Memorial Hospital, where children 
were brought for consultation spontaneously or referred by one of the study field 
workers visiting at home in regular interval. Children with cough or difficulty 
breathing were screened and enrolled if informed consent was obtained from one 
of the child’s caregivers, inclusion criteria were met, and exclusion criteria were 
not. The inclusion criteria were 2-35 months of age with non-severe or severe 
pneumonia as defined in the Integrated Management of Childhood Illness 
(IMCI) WHO manuals [114] and planning to stay in the study area for at least 6 
months. The exclusion criteria are presented in Table 3. Following stratification, 
according to severity of pneumonia and by age below or above one year, we 
randomized children in blocks of 16. Dispersible zinc or placebo tablets that 
were produced in France (Nutriset, Malaunay, France) were dissolved in water 
or breast milk and given daily for two weeks. The zinc tablets contained 10 mg 
of elemental zinc sulfate; children less than one year of age were given one and 
older children were given two tablets. Morbidity visits were done daily until 
recovery, which was defined as the first of two consecutive days with normal 
respiratory rate. 
 
Standard antibiotics (cotrimoxazole for 5 days as the first line antibiotic for non- 
severe and intravenous benzyl penicillin for severe pneumonia) were given to 
the trial participants. Oral cotrimoxazole was changed to amoxycillin by the 
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study physician if respiratory rate was still high 72 hours after enrollment. The 
study physicians changed the antibiotic regimen before 72 hours if the general 
condition of the child deteriorated or the child required hospital admission. For 
children with severe pneumonia, injected chloramphenicol was used as the 
second line antibiotic if lower chest indrawing (LCI) persisted after 48 hours of 
hospitalization. Children with wheezing were given 2 doses of 2.5 mg of 
nebulized salbutamol 15 minutes apart and reassessment was done after 30 
minutes. The approach and treatment of childhood illnesses was based on IMCI 
guidelines. Figure 1 shows the details of enrollment and the follow up process.
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      Paper III
29 drop out
         Scheduled visits     Passive surveillance 
299 drop outs Paper IV (spontanous visits)
129 drop outs
Figure 1. Enrollment and follow up process of clinical trial evaluating efficacy of zinc 
supplementation on childhood pneumonia and delayed effects
Children with cough/difficulty breathing (2-35 months of age)
(n=8,651)
WHO's defined pneumonia
(n=3,180)
Not meet inclusion 
criteria (n=5,470)
Randomized (n=2,628)
non-severe = 2,479
severe = 149
Could not enroll due 
to exclusion criteria 
(n=552)
Completed 14 days of 
supplementation = 2,599
Completed 3 months follow up = 
2,300
Total  numbers of follow up visit 
during 6 months = 7,380 visits
Completed 6 months follow up = 
2,171
Cough and 
cold =42% 
Pneumonia = 
34% 
Diarrhea= 
10%
Dysentery 
=2% 
Visits for other 
causes = 12%
Start follow up
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3.6.2. Follow up procedure for the six months period 
We followed the children for 6 months after enrollment. The caretakers were 
requested to bring their child for consultation whenever they felt it was 
necessary. Each visit was recorded by one of the study physicians by filling in a 
morbidity questionnaire after the clinical examination. Additionally, scheduled 
follow up visits were done at 3 and 6 months after enrollment at the field 
hospital. During these visits, the study physician obtained morbidity and 
hospitalization information for the preceding 2½ and 3 months, respectively. 
 
3.7. Ethical considerations 
The institutional review board at the Institute of Medicine, Tribhuvan 
University, Kathmandu, Nepal Health Research Council, Kathamdnu and the 
Regional Committee for Medical and Health Research Ethics (REK VEST), 
Norway approved both studies. The implementation of all aspects of the project 
was in agreement with the International Ethical Guidelines for Research 
Involving Human subjects as stated in the latest version of the Helsinki 
Declaration. Iron and deworming medicines were given to all enrolled subjects 
with anemia, according to national guidelines. Participation was voluntary; the 
participants could withdraw consent without giving reason at any time. All 
women and children were offered examination by a physician when indicated. 
Project card, which entitled a child to have free check up at the study hospital, 
were provided to all surveyed children irrespective of whether they were 
enrolled or not. Additionally, we provided 24-hour emergency and in-patient 
services at our study hospital to all children during the study period. An interim 
analysis by a data safety and monitoring board was carried out after 
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approximately one third of the children were enrolled in the clinical trial. The 
conclusion of this analysis was to continue the study without alterations to the 
protocol and to achieve the planned sample size. 
 
3.8. Definitions 
In the cross-sectional study, anemia among women was defined as Hb 
concentration < 12 g/dL. We also presented the anemia prevalence after 
adjusting for the altitude of Kathmandu [115]. Depleted iron stores was defined 
as plasma ferritin < 15 μg/L [116], and iron deficient erythropoiesis was defined 
as normal Hb with depleted iron stores and an increased p-TfR > 1.54 mg/L. 
IDA was defined as depleted iron stores and elevated p-TfR concurrent with 
anemia (Paper I).  
 
The cut-offs for defining zinc deficiency are different according to the time of 
blood collection and age group [117, 118]. The EAR of zinc using an unrefined 
plant based diet is 9 mg/day for women aged 13-18 y and 7 mg/day for non-
pregnant women older than 18 years [45]. The EAR of iron for non-pregnant 
women of reproductive age is 8.1 mg/day. Women consuming less than these 
cut-offs were considered to have inadequate intake (Paper I and II).  
 
In the clinical trial, pneumonia was defined according to the WHO/IMCI 
guidelines [114] i.e. history of cough or difficulty breathing combined with 
elevated respiratory rate i.e. (>40 breaths/minute for children >12 months and 
>50 breaths/minute for children 2-11 months of age) [114]. A child with cough 
and difficulty breathing and LCI was considered as having severe pneumonia. 
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Respiratory rates were counted twice and if required, even more times if the 
difference between the first and second count was more than 10. Whenever 
possible, we counted respiratory rates when the child was awake and quite/calm 
as it may increase during crying or agitation and decrease when the child is 
sleeping. Diarrhea was defined as the passage of three or more watery or loose 
motions in the last 24 hours with a recent change in stool character. Dysentery 
was defined as a diarrhea with a history of blood- mixed stool. 
 
3.9. Data management and statistical analysis 
The field supervisors manually checked all forms before they were sent to the 
computer facility for data entry. The data was double entered into Microsoft 
Visual FoxPro databases with computerized logic, range and consistency checks. 
The daily intake of various nutrients was calculated using Indian food tables 
from the Wfood2 software program [119]. The total zinc and iron contribution 
by different foods were derived from the nutritive values of the 24-hour dietary 
recalls, whereas the frequency of reported consumption was derived from the 
FFQs. The molar ratio of phytate to zinc (P:Z ratio) was calculated by dividing 
the millimoles of phytate intake (phytate intake in mg/molecular weight of 
phytate i.e. 660) by the millimoles of zinc intake (zinc intake in mg/molecular 
weight of zinc i.e. 65.4) [92]. 
 
Multiple linear regression analyses were used to determine the associations 
between Hb with other relevant variables (paper I). The generalized additive 
model derived graphs were generated using the statistical software R version 
1.9.0 to describe the relationships between Hb with p-TfR and iron intake (paper 
I) and plasma zinc with albumin concentration (paper II). We used the survey 
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(svy) commands in Stata to adjust the standard errors for the stratified cluster 
design in paper I and II. 
 
We compared the time until recovery from pneumonia and length of hospital 
stay between the treatment groups by Cox proportional hazards models. For the 
outcome treatment failure, we used logistic regression models (paper III). We 
coded the outcomes and interventions so that hazard ratios (HR) <1 and odds 
ratio (OR) >1 would represent beneficial effects of zinc administration.  
 
We used 6 months as the follow up period in the morbidity analysis for the 
children who were available both at 3 and 6 months after enrollment (paper IV) 
and the time until the first episode of diarrhea and pneumonia between the study 
groups were compared by Cox proportional hazard regression analyses. For 
children who had incomplete follow up, the last contact at the study hospital 
based on a scheduled (monthly-surveillance or 3- monthly) or spontaneous visit 
was used to calculate the total follow up time. If more than two months lapsed 
between any contact with the child and our study team, the child was censored 
on the day of his or her last encounter before this gap of follow up. The 
incidence rates for pneumonia and diarrheal illness were calculated by dividing 
the total number of a particular illness by the follow up days contributed by each 
child in the study and then multiplying this number by 30.42 to obtain a monthly 
rate. The analyses were undertaken using Stata (STATA Corp, Houston, TX) 
and in paper III and IV adjusted for multiple entries of the same child by the 
cluster option in the regression models. 
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4. Summary of results 
PAPER I   
Prevalence of iron deficiency and anemia among 
healthy women of reproductive age in Bhaktapur, Nepal 
In this cross-sectional study of 500 women of reproductive age in Bhaktapur, 
Nepal, we aimed to determine the prevalence of anemia and iron status assessed 
by biochemical markers and to explore the associations between markers of iron 
status and iron intake. The definitions and different stages of iron deficiency and 
percentile values of iron indices are shown in Table 4 and 5. The prevalence of 
anemia (hemoglobin concentration <12 g/dL) was 12% (n=58). The prevalence 
of depleted iron stores (plasma ferritin <15 μg/L) was 20% (n=98), whereas the 
prevalence of iron deficiency anemia (anemia, depleted iron stores with elevated 
transferrin receptor i.e. >1.54 mg/L) was 6% (n=30). Seven percent (n=35) of 
women had iron deficient erythropoiesis (depleted iron stores and elevated 
transferrin receptor but normal hemoglobin). Out of the 58 anemic women, 41 
(71%) also had elevated plasma transferrin receptor and 31 women (53%) also 
had depleted iron stores. Fifty-four percent of the women ate less than the 
recommended estimated average intake of iron. The main foods contributing to 
dietary iron were rice, wheat flour and green and dry vegetables. 
  
47 
Table 4. Stages of iron balance and its prevalence figures among 500 non-
pregnant women of Bhaktapur, Nepal 
Stages Hemoglobin,  
(g/dL) 
Plasma 
transferring 
receptor,  
(mg/L) 
Plasma ferritin,  
(μg/L) 
Prevalence, n 
(%) 
Normal iron 
status 
 > 12.0 < 1.54  > 15 264 (53%) 
Depleted iron 
stores 
   < 15 98 (20%) 
Iron deficient 
erythropoiesis 
 > 12.0 > 1.54   < 15 35 (7%) 
Iron deficiency 
anemia  
 < 12.0 > 1.54   < 15 30 (6%) 
Anemia of 
chronic disease 
< 12 < 1.54 > 50 5 (1%) 
Anemia*  < 12.0   58 (12%) 
* 41 (71%) women of those with anemia also had elevated plasma transferrin 
receptor, whereas 31 (53%) had depleted iron stores. 
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Table 5. Mean, median and interquartile ranges of zinc and iron parameters 
among children and women in Bhaktapur, Nepal 
Biochemical markers N Mean  SD 25th 
centile 
Median 75th 
centile 
Cross-sectional study participants (Among non-pregnant women 13-18 years) 
Hemoglobin, g/dL 136 12.8 1.5 12.3 13.1 13.8 
Ferritin, μg/L 136 26.9 35.6 12 23 33.6 
p-TfR, mg/L 136 1.8 1.3 1.2 1.4 1.9 
Plasma iron, μmol/L  136 12.8 5.7 8.7 12.3 16.8 
Zinc, μmol/L 136 8.5 2.1 7.1 8.4 9.4 
Among non-pregnant women (> 19 years) 
Hemoglobin, g/dL 364 13.4 1.2 12.8 13.5 14.1 
Ferritin, μg/L 363 38.3 27.5 19 33 52 
p-TfR, mg/L 363 1.6 0.6 1.2 1.4 1.7 
Plasma iron, μmol/L  363 14.8 5.7 10.8 14.7 18.6 
Zinc, μmol/L 362 8.5 2.6 7.2 8.3 9.5 
Clinical trial participants- baseline values- children 2-5 months of age 
Hemoglobin, g/dL 562 10.9 1.0 10.1 10.9 11.6 
Zinc, μmol/L 94 8.7 2.7 6.9 8.3 10.2 
6 months of age or above 
Hemoglobin, g/dL 2066 11.2 1.2 10.4 11.2 12 
Zinc, μmol/L 323 8.9 2.7 7.3 8.6 10.3 
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PAPER II   
Zinc deficiency is common among healthy women of 
reproductive age in Bhaktapur, Nepal  
We enrolled 500 non pregnant women in a dietary survey. The objective of this 
study was to estimate the proportion of women with zinc deficiency and describe 
its relation with biochemical and other dietary intake factors. The mean plasma 
zinc concentration was 8.5 μmol/L and the prevalence of zinc deficiency was 
78%-90% depending on the definition used. The interquartile range of zinc 
intake was 7.2-9.4 mg and prevalence of inadequate zinc intake was higher in 
women  18 years of age (69%) than in those that were older (29%). The mean 
phytate intake was 2,198 mg/day with a Phytate:Zinc molar ratio of 26:1. The 
intake of zinc was strongly and positively correlated with iron intake (r =0.79, 
P=<0.001) and predicted Hb concentration. The plasma zinc concentration was 
negatively associated with phytate intake (r= -0.15, P=0.003) but not with the 
intake of zinc. 
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PAPER III   
A randomized controlled trial of the effect of zinc as 
adjuvant therapy in children 2-35 months of age with 
severe or non-severe pneumonia in Bhaktapur, Nepal. 
To measure the efficacy of zinc administration as adjuvant therapy on duration 
and severity of community acquired pneumonia, we undertook a randomized 
clinical trial among Nepalese children 2-35 months of age.  Zinc was given for 
14 days in a daily dose of 10 mg elemental zinc for those less than one year of 
age and 20 mg for older children along with standard antibiotics according to the 
WHO Integrated Management of Childhood Illness guidelines. A total of 2,628 
episodes of pneumonia cases were enrolled from January 2004 to June 2007. 
Most of the cases (94%) were non-severe pneumonia. There was no difference in 
time to recovery between the study groups [hazard ratio (1.0, 95% CI: 0.96-1.1 
for non-severe and 1.1, 95% CI: 0.79, 1.5 for severe)]. The mean duration of 
time till recovery among those with non-severe pneumonia was 3.0 days (SD 
2.8) in the zinc group and 2.9 days (SD 2.9) in the placebo group. The 
corresponding figures in the severe pneumonia stratum were 5.5 (5.6) and 4.6 
(3.1) days, respectively. Thirty- nine percent of children with non-severe 
pneumonia in the placebo and 36% in the zinc group did not have any days of 
elevated respiratory rate after enrollment. The survival curves of day wise 
duration of non-severe and severe pneumonia episode is presented in Figure 2. 
Nineteen percent of the children required antibiotic change and there was no 
difference in the risk of such treatment failure (OR=0.95, 95% CI: 0.78, 1.2 for 
non-severe and 0.97, 95% CI: 0.42, 2.2 for severe pneumonia) between zinc and 
placebo recipients. Regurgitation within 15 minutes after administration of the 
first dose was observed in 14% of the participants in the zinc group and in 3.8% 
of placebo recipients (OR=3.9, 95% CI: 1.2-5.5).
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Figure 2: Kaplan Meier survival curves of non-severe (Figure. 2a) and 
severe pneumonia (Figure. 2b) among 2-35 months old children in 
Bhaktapur, Nepal  
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PAPER IV   
Two weeks of zinc administration to Nepalese children 
with pneumonia does not reduce the incidence of 
pneumonia or diarrhea during the next 6 months 
We measured whether or not 14 days of zinc administration given to children 
presenting with community acquired pneumonia prevented diarrhea and 
respiratory tract infections for another six months. Children enrolled in the trial 
described in PAPER III were followed for up to six months after enrollment. 
These children visited the clinic 7,380 times for consultations with the study 
doctors.  Most of these visits were for cough or cold and followed by pneumonia 
or diarrhea. Every second child from both groups visited at least once for 
pneumonia and one in five made a visit for diarrhea. The median numbers of 
days until the first episode of pneumonia and diarrhea were similar in the two 
study groups. The hazard ratios (95% CI) were 1.02 (95% CI: 0.92, 1.14) for 
non-severe pneumonia, 1.11 (95% CI; 0.72, 1.73) for severe pneumonia, 1.07, 
(95% CI; 0.91, 1.26) for diarrhea, and 0.96 (95% CI; 0.69, 1.34) for dysentery. 
The total numbers of visits for these illnesses were also similar in both trial arms. 
The plasma zinc concentration was significantly higher at the end of 
administration (9.2 μmol/L in the placebo and 14.6 μmol/L in the zinc group, P= 
<0.0001) among those who received zinc. However, the plasma zinc 
concentration was not significantly different between the study groups on blood 
samples taken on day 45th or 90th after enrollment (Table 6).
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Variable 
N Mean Std. Dev. Mean 
changes   
% with 
<9.9 
μmol/L 
Min Max 
Baseline        
Placebo 211 8.8 2.3  70.1% 2.7 15.8 
Zinc  206 8.9 2.9  70.3% 2.5 35.6 
P-value  0.5      
14 days        
Placebo 89 9.26 2.5 0.5 (3.1) 71.1% 2.5 22.9 
Zinc 88 14.62 7.3 5.8 (6.7) 24.7% 7.3 51.7 
P-value   <0.005  <0.005    
45 days        
Placebo 38 9.7 2.3 0.1 (2.3) 56.4% 4.8 12.7 
Zinc 43 9.8 2.2 1.2 (3.2) 44.4% 5.7  16.1 
P-value   0.9  0.1    
90 days        
Placebo 41 9.0 2.3 0.6 (2.5) 70.7% 3.9 15.3 
Zinc 39 9.9 3.3 0.8 (3.8) 55.0% 4.6 26.3 
P-value   0.1  0.7    
Table 6. Plasma zinc status by treatment groups at baseline, and 14, 45 and 90 
days after enrollment in zinc intervention trial for pneumonia in Nepal 
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5. Discussion 
In these studies, we have estimated the status and intake of two important 
micronutrients (iron and zinc) in women of reproductive age and measured the 
efficacy of zinc for the treatment and prevention of community acquired pneumonia 
in young children. Zinc deficiency was much more common than was iron deficiency 
and affected approximately four of five women, whereas iron deficiency was found 
among one in five women. The intake of iron was positively associated with Hb 
concentration, but the intake of zinc was not associated with plasma zinc 
concentration. Phytate intake contributed importantly to a high P:Z molar ratio in 
many women’s diet and this ratio was negatively associated with their plasma zinc 
concentration. Two weeks of zinc administration during severe or non-severe 
community acquired pneumonia among the trial children in Nepal did not reduce the 
severity or duration of the illness. The incidence of pneumonia and diarrhea during 
the 6 months follow up period of these children was also similar in the placebo and 
intervention groups.    
 
5.1. Selection and compliance –Cross-sectional study  
For the cross-sectional part of the PhD project (paper I and paper II), within each 
stratum of local residents or those working in carpet factories, we randomly selected 
clusters. The stratum with local resident women constituted 80% of the total sample 
and the sampling procedure went smoothly throughout the study. However, in the 
stratum consisting of women from carpet factories there was frequent migration and 
we had to update the list of eligible women after the study start. The local resident 
women belonged primarily to the Newar ethnic group and were living in a semi-
urban area. Whereas women in carpet factories usually had migrated from other parts 
of Nepal and mostly belonged to Tamang and Magar ethnic group. Thus, the findings 
presented in this study may have been somewhat different if studied in other ethnic 
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groups of Nepal. However, by deliberately recruiting women in carpet factory, other 
ethnic groups were also to some extent represented.  
 
5.2. Selection and compliance -Clinical trial  
For the clinical trial, children were recruited through spontaneous visits to the study 
hospital or by identification of sick children by field workers through a continuous 
surveillance of the population (paper III and IV). A total of 98.6% of enrolled 
children completed the prescribed course of zinc or placebo for 14 days and 85% of 
them were available at the 6 months follow up visit, which reflect good compliance. 
The home visits of field workers were checked independently by supervisors in about 
4% of the total visits.  
 
5.3. Iron deficiency and anemia 
In a representative sample of 500 non-pregnant women, we found an anemia 
prevalence of 12% which is lower than what was estimated in the nationwide 1998 
survey which showed a prevalence of 68% [120]. More recent data from the national 
demographic health survey estimated a substantial lower anemia prevalence but this 
figure was still three fold higher than what we found [14].  Most of the women with 
anemia had mild or moderate anemia but were altered erythropoiesis and depleted 
iron stores. As pointed out by Guyatt et al. [121] iron stores in our body start to 
decrease already at a ferritin concentrations of 30 – 40 μg/L. Also, living at a high 
altitude (i.e.1400 m above sea level) may increase the demand of iron for 
erythropoiesis. 
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Compared with older women, adolescent girls, 13-18 years of age, had about twice as 
high prevalence of anemia and iron deficiency. This indicates that this group is at a 
higher risk, probably because of inadequate intake, growth spurt and/or hormonal 
changes. Although, anemia is considered a huge public health problem in Nepal, most 
of the data is based on only estimation of Hb concentration. The etiology of anemia 
has not been extensively studied, however, and it is assumed that most cases are 
caused by iron deficiency. The finding of comparatively low Hb concentration among 
women from carpet factories was not unexpected. The women from the carpet 
factories have in general lower socio-economic background and had migrated from 
other parts of Nepal, and do not usually have their own home and are often without 
support from a joint family.  
 
Our study is, to our knowledge, the first to assess anemia and iron deficiency using 
multiple iron parameters from a representative sample of healthy non-pregnant 
women in Nepal. The relatively low prevalence of anemia and iron deficiency in our 
study could be due to the fact that we enrolled apparently healthy women and from an 
area that is not endemic for malaria, hookworm infestation or hemoglobinopathies. 
Furthermore, we found positive associations of Hb with age, parity and use of Depo-
Provera (depot medroxyprogesterone acetate). Nearly half of the women reported 
using Depo-Provera which may contribute to the relatively high Hb concentration. 
This could be due to cessation of menstruation after Depo-Provera and also 
enrichment of iron stores from iron supplementation during pregnancy and lactation. 
 
Inadequate intake of iron was observed in more than half of the women and the intake 
of iron was positively and linearly associated with Hb concentration when the intake 
was less than the EAR (paper I). Meat contributed only 5% of the total iron intake, 
indicating that most of the consumed iron was from non-heme food sources. The 
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absorption of iron is mainly controlled by the iron requirements of the body and 
affected by several enhancers and inhibitors in foods.  
 
The findings that a high proportion of women had anemia without iron deficiency 
needs further clarification. Although, iron is a main cause of anemia, deficiency of 
other nutrients like folate, vitamin B12, vitamin A and zinc may also cause anemia 
[96, 122, 123]. The prevalence of cobalamin deficiency based on low plasma 
cobalamin and high plasma homocystein and methylmalonic concentration among 
pregnant [95] and non-pregnant [124] women of Nepal, has been reported before. We 
also measured the cobalamin and folate status in this sample of women and we found 
that cobalamin deficiency was common. However, neither folate nor cobalamin was 
associated with hemoglobin concentration or anemia [124].    
 
5.4. Zinc deficiency  
We found a high prevalence of zinc deficiency affecting more than three fourths of 
the non-pregnant women. Most of women with anemia (93%) also had zinc 
deficiency. Plasma zinc concentration is considered the best method for estimating 
the prevalence of zinc deficiency in populations, if sufficient precautions are taken 
during sampling and processing and interpretation [89]. Public health intervention 
strategies including dietary diversification and food fortification, are recommended, if 
the prevalence of zinc deficiency in a given population is more than 20% [125]. 
Based on the stunting prevalence in children < 5 years of age, which is also used as a 
proxy for the estimation of zinc deficiency, Nepal belongs to a category of countries 
with severe zinc deficiency [117]. Our findings support this assessment but it is 
unclear whether the stunting prevalence of children under 5 years of age can be used 
for estimating the prevalence of zinc deficiency in women. Our findings of high 
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prevalence of zinc deficiency is also supported by other studies in Nepal [19], India 
[126] and other developing countries [127, 128]. The intake of zinc was not 
associated with plasma zinc concentration in our study. The intake of phytate, 
however, was negatively associated with the plasma zinc concentration. The positive 
association of zinc intake with intake of iron and hemoglobin concentration is 
probably explained by the fact that both of the minerals are present in same food 
sources. This may also explain our finding of a positive association of plasma zinc 
with Hb, which is in concordance with findings in other studies [122, 129]. However, 
it is noteworthy that zinc deficiency in this population is four fold-higher than that of 
iron deficiency. We identified variables that were positively associated with the Hb 
concentration in this population such as age, parity and the use of Depo-Provera 
contraceptive injection but none of these factors were associated with plasma zinc 
concentration (data not shown). A recent study of pregnant women in Ethiopia also 
found high prevalence of zinc deficiency and low prevalence of ID [128]. 
 
Although, plasma zinc did not differ by age, the prevalence of inadequate zinc intake 
was found to be twice as high among those younger than 18 years of age compared to 
those who were older. This could be because of the higher EAR for the younger 
women which is 2 mg higher. The findings that the zinc deficiency prevalence was 
even higher than what would be expected from the proportion of inadequate zinc 
intake could be explained by the fact that high dietary phytate reduced the 
bioavailability of zinc. This explanation is supported by our finding that phytate, but 
not zinc intake was associated with the plasma zinc concentration. 
  
Because of its crucial role in maintaining immunity, growth and cell division [39], 
and in prevention of common childhood infections, zinc deficiency is estimated to be 
responsible for 4.4% of all deaths among children 5 years of age globally [42]. Zinc is 
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also required during pregnancy for foetal growth and for maternal tissue accretion 
[130]. Observational studies have shown that poor zinc status is associated with 
negative pregnancy outcomes [46], reduced birth weight [47] and congenital 
anomalies. The effect of zinc supplementation during pregnancy has also been 
investigated in several clinical trials in developing countries. A recent meta-analysis 
showed a 14% and statistically significant reduction in the risk of prematurity which 
may again have impact on neonatal and infant mortality. However, there were no 
substantial or significant effects on other outcomes, such as birth weight, neonatal 
mortality, post-natal morbidity, birth asphyxia, hypertension, or eclampsia in the 
mother [52].  
 
Apart from age, Hotz et al. suggested that gender; time of blood collection and 
fasting status should be taken into account when interpreting plasma zinc status [131]. 
In our study, the mean plasma zinc concentration did not vary with time of the day of 
blood collection. This may be because we collected blood only between 9 AM and 3 
PM. The mean zinc concentrations in fasting specimens or specimens drawn from 
women who had not had a morning meal were substantially higher than in non-
fasting specimens, which are in concordance with other findings [132, 133]. 
However, it is interesting to note that this difference was observed when the women 
had had their last meal more than 2 hours earlier. It suggests that overnight fasting, as 
found in a study by Wallock et al. [134], or fasting for longer time periods results in 
increased plasma zinc concentration, whereas fasting for shorter time periods (2-3 
hours) does not change plasma zinc concentration much.  
 
5.5. Intake of phytate 
Phytate, which is abundant in plant based foods like legumes, nuts, and cereal grains, 
is an organic compound which binds to minerals like zinc and iron and therefore 
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interfere with the absorption of these metals in the gastrointestinal tract [135]. Several 
factors relating to food processing (such as storage, milling, cooking) as well as the 
variety of dietary components in food composition tables may affect the interpretation 
of phytate intake of individuals or groups. However, phytates was found to be 
degraded only marginally in a study measuring the degree of degradation in Indian 
style cooking [136]. Moreover, the estimated phytate content in the Wfood2 food 
composition tables has been between 353-845 mg and 20-617 mg per 100 g for the 
local staple grains and legumes, respectively. The phytate values in these food 
composition tables are comparatively lower than in the tables from other sources 
[137]. This indicates that our estimated phytate contribution could have been under- 
rather than overestimated.  
  
5.6. Interpretation of nutritive and plasma zinc values 
Due to the lack of national food composition table values for Nepal, we have used 
Indian food tables from the wfood2 computer software package [119]. The nutritive 
value may differ according to the soil [44], storage and processing of foods during 
cooking and other factors. Thus, the values, which we have obtained from Indian 
tables, may be somewhat different from those of the nutritive values of local foods. 
Similarly, for the interpretation of dietary adequacy indicators like EAR cut-offs, we 
have chosen international values set by the National Academy of Sciences, US [113], 
which may also over- or underestimate our intake results. The cut-off values set by 
the IZiNCG for the estimation of zinc deficiency was based on a healthy US 
population without infection on the day of blood sampling [131]. We have enrolled 
healthy women for the estimation of zinc deficiency but our enrolled children had 
acute respiratory illnesses which may have influenced their plasma zinc concentration 
[72]. Unfortunately, there are no standardized cut-off values indicating zinc 
deficiency by measuring plasma zinc during illness.    
  
 
62 
  
5.7. Zinc administration for the treatment of community acquired pneumonia 
Although recent years have seen substantial reductions in child mortality and 
morbidity [138], one in every fifth childhood death is still caused by pneumonia [5, 
139]. Most of these deaths are caused by bacterial pneumonias, which probably 
constitute at least 50% of hospitalized cases of pneumonia in children [78]. Reduction 
of the number of childhood pneumonia deaths is an important prerequisite for the 
achievement of the Millennium Development Goal-4 [140].  Improvement in zinc 
nutrition is considered as one of the effective ways to prevent childhood pneumonia 
together with increasing immunization coverage, exclusive breastfeeding prevalence 
and improving the children’s general nutritional status [141]. We enrolled 2,628 
episodes of community acquired pneumonia in 2-35 months old children and did not 
find any beneficial or harmful effect of oral zinc in terms of severity or duration of 
illness. 
 
To our knowledge, this is the first study of the efficacy of zinc as adjuvant therapy in 
primarily non-severe community acquired pneumonia. We used the WHO/IMCI 
definition for the diagnosis of pneumonia, which is based on fast breathing. In this 
definition, the diagnostic specificity has been compromised in order to ensure high 
sensitivity [57, 78]. Apart from bacterial pneumonia, several other illnesses such as 
malaria, enteric fever, reactive airway disease, viral bronchiolitis, anemia and other 
febrile illnesses may also cause fast breathing [142-144]. Earlier, a positive effect of 
zinc was observed primarily when the etiology was of presumed bacterial origin [73, 
80], though this notion was challenged by the results from a trial undertaken in India 
[83]. Thus, in a randomized double-blind trial in young children with pneumonia in 
Vellore, there were no overall effects of zinc as adjunct therapy. Having CRP 
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concentration > 40 mg/L, which indicate a bacterial etiology, was associated with a 
negative effect of zinc. 
 
The mean baseline plasma zinc concentration in our study was 8.9 μmol/L (SD 2.6) 
which is lower than in the children included in earlier studies on pneumonia, where it 
ranged from 9.9 -11.0 μmol/L [145]. When using zinc for the treatment of acute 
diarrhea, low baseline zinc status was identified as one of the subgroups where zinc 
was particularly efficacious. By using the cut-off of IZiNCG (<9.9 μmol/L), 70% of 
our enrolled children were zinc deficient. However, we could not observe beneficial 
effect of zinc supplementation even in this sub-group of children with low plasma 
zinc.  
 
We changed to second line antibiotics within 72 hours in 21% and 20% of the 
children receiving zinc or placebo, respectively. The standard WHO case 
management of pneumonia recommends a change to second line antibiotic after 48 
hours [146], if there is no response by the first line antibiotic. Had we used this 
guideline, more than 50% of children would have required antibiotic changes, again 
equally distributed between the intervention arms (data not shown).  
 
Resistance to antibiotics is a growing problem globally, particularly in developing 
countries [147]. In Nepal and in other countries more and more children with 
presumably viral cough and cold or diarrhea receive treatment with antibiotics [71, 
148-150]. One of the concerns using the WHO/IMCI recommendations for treatment 
of non-severe pneumonia is that it increases the unnecessary use of antibiotics. The 
results from our study provided information that a substantial proportion of antibiotic 
prescription could be averted by prolonging duration of antibiotic change up to 72 
  
 
64 
hours without causing any further risk for children in our research setting. Recently, 
based on their follow up study among 876 children in Pakistan, Hazir et al. also 
suggested not to conclude with treatment failure if a child does not deteriorate from 
non-severe pneumonia even on day 3 [151].   
 
The finding of vomiting/regurgitation in zinc recipients was consistent with our 
previous report from the same setting [63] and elsewhere [152]. Most of these 
vomiting/regurgitation episodes occurred on the first day of enrollment. The exact 
mechanism behind regurgitation and vomiting after zinc administration is not known 
but it is one of its most common side effects [153]. Vomiting during an illness such as 
pneumonia may lead to worsening of the clinical picture because of aspiration, 
particularly among young infants. Fortunately, in our trial, the zinc induced vomiting 
was not higher among the young children compared to the older study participants.  
 
5.8. Zinc supplementation and delayed effects 
Preventive zinc supplementation trials in developing countries have shown beneficial 
effects in terms of reduced incidence of common childhood illnesses such as 
pneumonia and diarrhea, where zinc deficiency is presumed to be high. In a pooled 
analysis published in 1999, 3 small short-course zinc supplementation trials from 
selected groups of children were included and the effect size on prevention of 
diarrheal and respiratory illness was comparable with that found with continuous 
preventive trials [54]. A subsequent study by Rahman et al. in Bangladesh [86, 154], 
found a reduction on diarrheal incidence but increased respiratory illness risk and no 
effect on growth for 6 months of follow up. Two additional zinc studies from 
Bangladesh by Brooks et al. [9] and Baqui et al. [155] reported substantial benefits in 
terms of morbidity and mortality reduction when zinc were given weekly for healthy 
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kids or intermittently during each episode of diarrhea. However, the results from 
trials measuring the effects of short-courses of zinc supplementation are not 
consistent. The children in our trial who received zinc during pneumonia did not have 
more or less infections over the subsequent six months compared to children that 
received placebo (Paper IV). Our findings of no effect in terms of reduction of 
incidence of diarrheal and respiratory illnesses is in line with the results from our own 
previous study based on one month of follow up [63] and a study by Fisher-Walker et 
al. [83], undertaken in 3 countries among children < 6 months of age with acute 
diarrhea.  
 
In the present study with high precision, we have shown that zinc administration had 
no effect on the time until the first subsequent episode of non-severe pneumonia, 
severe pneumonia, diarrhea or dysentery. To record illnesses during the follow up 
period, we used different approaches. The field hospital is located within walking 
distance for more than 90% of the enrolled children and is one of the main established 
pediatric service centers in this area. Additionally, we provided free treatment 
facilities for enrolled children. So, we assume that we recorded most of the major 
illnesses from enrolled kids, which also confirmed by similarities on record between 
physicians and mother’s recall. 
 
Unlike vitamin A and iron, zinc is not stored in our body and its turnover is rapid, and 
zinc loss is augmented by frequent infections that are common among children in low 
income countries [156]. This may explain why beneficial effects were observed in 
continuous [55] or intermittent supplementation trials where zinc was given weekly 
[9] or in each episode of diarrhea [85] but not when zinc was given at one point in 
time [157, 158]. The plasma concentration in our study increased only until the 
administration period was over and not on 45 or 90 days after enrollment. So, it may 
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not be surprising that we could not see any beneficial effect on morbidity during the 3 
and 6 months follow up period.   
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6. Main conclusions and recommendations 
1. In a cross-sectional study among non-pregnant women in Bhaktapur, Nepal, 
the prevalence of anemia, iron deficiency and iron deficiency anemia were 
12%, 20% and 6%, respectively. Most of the iron containing foods was non-
heme sources like rice, green vegetables and wheat whereas heme iron 
contributed only 5% of the total iron intake. Age, parity and use of Depo-
Provera contraceptive injection were positively associated with hemoglobin 
concentration.  
 
2. The prevalence of iron deficiency and anemia in our study was substantially 
lower than the national estimates, which indicates that the prevalence may 
differ according to geographical location, dietary pattern and ethnic 
background. Local adaptation of the national guidelines for iron deficiency 
prevention programs may accordingly be needed. Carpet factory women, who 
represent women from other parts of the country, had a higher prevalence of 
iron deficiency and anemia than the local residents. 
 
3. We also documented that zinc deficiency was very common in women of 
reproductive age, affecting 78%-90% depending upon the cut-offs used. The 
intake of zinc was not associated with plasma zinc concentration, while 
phytate intake was. The median intake of phytate was > 2 gram per day and 
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the mean P:Z molar ratio was 26:1, indicating profound inhibition of zinc 
absorption in many of our study participants. 
 
4. The prevalence of zinc deficiency in women of reproductive age was 
substantially higher than the prevalence of iron deficiency in this community, 
and possible options for improvement of these nutrients include consumption 
of micronutrient enriched foods, dietary fortification and supplementation. The 
P: Z molar ratio and the intake of phytate can be reduced by milling, 
germination, fermentation and soaking of local foods before preparation and 
consumption. 
 
5. Future studies should address possible health consequences of zinc deficiency, 
including in babies born to women with this deficiency.    
 
6. Zinc administration as an adjuvant to standard antibiotic therapy among young 
Nepalese children neither reduced the treatment failure risk nor the duration of 
the pneumonia episode. Our study is not an argument for expanding oral zinc 
for management of acute lower respiratory tract infections in children. 
 
7. Short-course zinc administration during community acquired childhood 
pneumonia increased plasma zinc concentration only until the last day of zinc 
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administration. To maintain proper zinc stores, intermittent or continuous 
supplementation may be necessary. The short-course zinc administration did 
not reduce the risk of respiratory or diarrheal illness during the 6 months of 
follow up. In future studies, priority should be given to identify subgroups of 
children who might benefit from short-course of zinc administration.  
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